Drug Topics
MARCH 28, 2024
Following quality concerns voiced by the FDA regarding plastic syringes made in China, medical technology company BD has announced it will increase its production of plastic syringes in the US.
STAT
MARCH 28, 2024
While an increasingly anxious world watched a new coronavirus spread across the globe in early 2020, veteran immunologist Rafi Ahmed quickly grasped that his field was about to experience something truly extraordinary. His former student Ali Ellebedy was gnawed by frustration as Covid shutdowns stalled his influenza research; it took until the summer, when mass vaccination planning hit his radar, before the same realization kicked in.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MARCH 28, 2024
This week, a divided America watched as the Supreme Court heard oral arguments regarding whether to reinstate restrictions on accessing mifepristone, an essential drug used in medication abortion.
STAT
MARCH 28, 2024
The staff of the Institute for Clinical and Economic Review, or ICER, are known as the nerds of the drug industry: bespectacled killjoys who emerge a few times a year to scold drugmakers for pricing their latest cancer or MS advance far beyond reason. But last year, its staff sat down and concluded a forthcoming treatment was worth up to $3.9 million — more than any medicine in history, more than a 45-year supply of Humira, the autoimmune drug often held up as an emblem of America’
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
MARCH 28, 2024
Tenofovir alafenamide was originally approved by the FDA in 2016 to treat adults with chronic HBV infection with compensated liver disease and in 2022 to treat pediatric patients aged 12 years and older.
STAT
MARCH 28, 2024
The financial ties between drug and device makers and some physicians remains pervasive, despite concerns such relationships may influence medical practice, according to a new analysis of payments made over a recent 10-year span. From 2013 to 2022, pharmaceutical and device companies made more than 85 million payments totaling $12.1 billion to approximately 826,300 physicians.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
MARCH 28, 2024
WASHINGTON — There’s a fight brewing over the future of decaf coffee. Consumer health advocates are petitioning the Food and Drug Administration to ban a key chemical, methylene chloride, used to decaffeinate coffee beans. While the chemical is almost entirely removed during the decaffeination process, advocates say that a little-known nearly 66-year-old federal law mandates the agency ban the additive because it has been proven to cause cancer in rodents.
Fierce Healthcare
MARCH 28, 2024
This is a developing story and will be updated following Walgreens' Q2 earnings call this morning. | Walgreens lost nearly $6 billion in its fiscal 2024 second quarter to write down the value of its investment in primary care clinic chain VillageMD.
STAT
MARCH 28, 2024
Diabetes and obesity GLP-1 drugs like Ozempic, which can delay stomach emptying, have introduced a predicament for patients undergoing surgeries and endoscopies — the patients in some cases may still have food in their stomach even if they’ve fasted, raising concerns that they could accidentally breathe food into their lungs during the procedures.
Fierce Healthcare
MARCH 28, 2024
The U.S. | While there are common struggles for the primary care model in many wealthy countries, the U.S. is a particularly poor performer with overburdened physicians and unsatisfactory patient care in general.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
MARCH 28, 2024
Oprah Winfrey, true to form, is forcing America to yet again grapple with a complex topic: weight loss. Her full-throated endorsement on national television last week for using GLP-1 drugs like Ozempic and Wegovy to treat obesity has opened the door for an important conversation about the use of these drugs for people struggling with their weight. As a physician focused on obesity and metabolic disorders, I was troubled by Oprah’s support for these drugs.
Pharmacy Times
MARCH 28, 2024
As the full act will be enforced in November 2024, all medication dispensers must ensure they’re fully prepared.
STAT
MARCH 28, 2024
WASHINGTON — Supreme Court Justice Samuel Alito had a clear question at Tuesday’s arguments over the abortion pill mifepristone: If the doctors who brought that case can’t sue the FDA over a drug’s label, who can? And when? “Is there anybody who can sue and get a judicial ruling on whether what FDA did was lawful? And maybe what they did was perfectly lawful, but shouldn’t somebody be able to challenge that in court?
Fierce Healthcare
MARCH 28, 2024
Robert Horry's daughter, Ashlyn, spent the first six months of her life at Texas Children's Hospital in Houston hooked up to oxygen. | Better known for his clutch shots in the NBA finals or his commentary on Lakers games today, Robert Horry is joining SureCo, a company helping employers administer ICHRA plans, as a chief impact officer.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
MARCH 28, 2024
The United Kingdom has released comprehensive data showing which institutions have failed to register their clinical trials, a move that was hailed by transparency advocates who say this marks the first time that a country has taken such a step. Last week, the Health Research Authority posted complete registration information for 1,545 trials, including the name of the study, the sponsor, and registration number for the trial.
Fierce Healthcare
MARCH 28, 2024
Kaiser Permanente and a pair of investment firms have unveiled a joint venture to help older, low-income adults receive care support without needing to be moved from their homes. | The joint venture operates under a capitated payment model and aims to keep low-income seniors in their homes with a combination of medical and social services. It's initially targeting those living in Sacramento and Los Angeles.
Fierce Pharma
MARCH 28, 2024
Johnson & Johnson will get a do-over in its defense against more than 50,000 lawsuits that claim the company’s iconic baby powder can cause ovarian cancer. | Johnson & Johnson will get a do-over in its defense against more than 50,000 lawsuits claiming that the company’s iconic baby powder can cause ovarian cancer. A New Jersey court ruled on Wednesday that J&J can contest the scientific findings that back those cases.
pharmaphorum
MARCH 28, 2024
Explore the cutting-edge innovations featured at WIRED Health 2024, including insights on Alphafold, clean air technology, and Lingo. Stay informed about the latest disruptors shaping the future.
STAT
MARCH 28, 2024
Who gets to sue the FDA? Is pharma caught in a trade war? And what does “AF” stand for? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Sarah Owermohle joins us to explain the Supreme Court case that could have dramatic effects on access to medication abortion — and the development of new medicines.
Fierce Healthcare
MARCH 28, 2024
Three-quarters of polled health equity executives expect their area of expertise to become a greater priority over the coming year, a new EY report has found. | Though organizations are increasingly shifting from collecting data to using it to inform efforts, bigger entities with more resources tend to be more mature in these capabilities.
STAT
MARCH 28, 2024
Top of the morning to you and a fine one it is. Despite cloudy skies hovering over the Pharmalot campus, our spirits remain sunny. How so? We will trot out a bit of wisdom from the Morning Mayor, who taught us that “every new day should be unwrapped like a precious gift.” So while you tug on the ribbon, we will proceed by brewing another cup of stimulation.
pharmaphorum
MARCH 28, 2024
Scientists say a test for motor neuron disease, based on an aptamer for biomarker TDP-43 in brain tissue, could detect at-risk people before symptoms develop.
STAT
MARCH 28, 2024
This is the inaugural edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox. Hello! Welcome to the premiere issue of Adam’s Biotech Scorecard. I’m excited to get started. Let’s do this! (By the way, the AF in the logo are my initials, not the “other” AF.
pharmaphorum
MARCH 28, 2024
Akebia’s Vafseo has been approved in the US as a treatment for anaemia caused by chronic kidney disease in dialysis patients, the first direct rival to GSK’s Jesduvroq.
STAT
MARCH 28, 2024
Today is the inaugural publishing day for Adam’s Biotech Scorecard — a subscriber-only newsletter offering senior reporter Adam Feuerstein’s no-holds-barred perspective on the rapidly shifting world of biotech. Sign up to get it in your inbox here. Hello! It’s Meghana. Today, we’re reading about the world’s costliest drug, plus we learn about immune senescence and a potential cause for a kidney autoimmune disease.
Drug Topics
MARCH 28, 2024
Check out these can't-miss Workflow Wednesdays sessions in April.
Pharmacy Times
MARCH 28, 2024
The authors note that these findings provide opportunities for health care professionals to utilize social media to reach patients and share accurate information.
The Checkup by Singlecare
MARCH 28, 2024
Ibuprofen can be taken along with amoxicillin, but you should recognize the benefits and risks of doing so. The most popular nonsteroidal anti-inflammatory drug ( NSAID ), ibuprofen , is a fever-reducer and pain-reliever. Meanwhile, amoxicillin is a classic member of the penicillin antibiotic class , used in treating ear and sinus infections , pneumonia , strep throat, urinary tract infections , and skin infections.
The Guardian - Pharmaceutical Industry
MARCH 28, 2024
Drug companies urged to ‘release stranglehold’ on medicines such as Ozempic and Trulicity, as millions are priced out of treatment Drug companies are pricing diabetes medicines at almost 400 times the level necessary to make a profit, according to a new study. Researchers said it would also be possible for modern insulin pens, which are safer and offer more accurate doses than vials and syringes, to be used even in low-income countries if pharmaceutical firms “put people before their astronomica
The Checkup by Singlecare
MARCH 28, 2024
Amoxicillin is an antibiotic approved by the U.S. Food and Drug Administration (FDA) to treat many bacterial infections. These include ear infections, sinus infections, lower respiratory tract infections, and urinary tract infections (UTIs). It can also be combined with other medications to treat Helicobacter pylori infections and duodenal ulcer disease.
Pharmaceutical Technology
MARCH 28, 2024
Nanoscope Therapeutics released promising top-line results for its RESTORE trial, which is studying the gene therapy MCO-010 in patients with retinitis pigmentosa (RP).
pharmaphorum
MARCH 28, 2024
New data for Beckley Psytech's psychedelic therapy for treatment-resistant depression builds anticipation for a phase 2b readout later this year
Fierce Pharma
MARCH 28, 2024
Authors: | Gain the competitive edge with accurate probability of success assessments to uncover undervalued companies and early-stage assets for acquisitions.
Pharmaceutical Technology
MARCH 28, 2024
According to the CDC, over 64 cases of measles have been documented in the US in 2024, already exceeding 2023's total of 58.
Expert insights. Personalized for you.
212 
Let's personalize your content